Publications by authors named "Thomas MacGregor"

Claim this Profile
S
Systemic Inflammation and Anhedonic Responses to an Inflammatory Challenge in Adults With Major Depressive Disorder: A Randomized Controlled Trial.
Jonathan Savitz, Leandra K Figueroa-Hall, T Kent Teague, Hung-Wen Yeh, Haixia Zheng, MacGregor Thomas

Am J Psychiatry· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Near infra-red fluorescence identification of the thoracic duct to prevent chyle leaks during oesophagectomy.
Thomas G Barnes, Thomas MacGregor, Bruno Sgromo, Nicholas D Maynard, Richard S Gillies

Surg Endosc· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated Systemic Inflammation Is Associated with Reduced Corticolimbic White Matter Integrity in Depression.
MacGregor Thomas, Jonathan Savitz, Ye Zhang, Kaiping Burrows, Ryan Smith

Life (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast Pixelated Detectors in Scanning Transmission Electron Microscopy. Part II: Post-Acquisition Data Processing, Visualization, and Structural Characterization.
Gary W Paterson, Robert W H Webster, Andrew Ross, Kirsty A Paton, Thomas A Macgregor

Microsc Microanal· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence and adhesion evaluation of transdermal clonidine following a change in excipient supplier.
Jerome Ehrlich, Bonnie Beck, Ralf Thiedmann, Kristell Marzin, Thomas MacGregor

Int J Clin Pharmacol Ther· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer.
Esme J Hill, Corran Roberts, Jamie M Franklin, Monica Enescu, Nicholas West, Thomas P MacGregor

Clin Cancer Res· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy.
John M Findlay, Francesc Castro-Giner, Seiko Makino, Emily Rayner, Christiana Kartsonaki, Thomas P MacGregor

Nat Commun· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-response modelling for empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in patients with type 2 diabetes.
Matthew M Riggs, Leo J Seman, Alexander Staab, Thomas R MacGregor, William Gillespie

Br J Clin Pharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steady-state pharmacokinetics of nevirapine extended-release tablets in HIV-1-infected children and adolescents: an open-label, multiple-dose, cross-over study.
Carlo Giaquinto, Gabriel Anabwani, Cornelia Feiterna-Sperling, James Nuttall, Kgosidialwa Mompati, Thomas R MacGregor

Pediatr Infect Dis J· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.
Stephanie B Hatch, Lonnie P Swift, Simona Caporali, Rebecca Carter, Esme J Hill, Thomas P MacGregor

Int J Cancer· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the first year of the Oxpal Medlink: A web-based partnership designed to address specific challenges facing medical education in the occupied Palestinian territories.
Rose S Penfold, Mohammad A Ali, Adam M Ali, Ishita Patel, Thomas MacGregor

JRSM Open· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with type 2 diabetes.
Matthew M Riggs, Alexander Staab, Leo Seman, Thomas R MacGregor, Timothy T Bergsma

J Clin Pharmacol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of absorption, distribution, metabolism, and elimination genotyping data into a population pharmacokinetic analysis of nevirapine.
Thorsten Lehr, Jing Yuan, David Hall, Heike Zimdahl-Gelling, Hans Guenter Schaefer, Thomas R MacGregor

Pharmacogenet Genomics· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is less clinical research being published by surgeons in the United Kingdom?
Alexander W Phillips, Thomas P Macgregor, Radu Mihai

Surgeon· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coadministration with lopinavir and ritonavir decreases exposure to BILR 355, a nonnucleoside reverse transcriptase inhibitor, in healthy volunteers.
Fenglei Huang, Paul Scholl, David B Huang, Thomas R MacGregor, Richard Vinisko

J Clin Pharmacol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Forgiving" a missed daily dose.
Thomas R Macgregor

AIDS Res Hum Retroviruses· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of a pharmacokinetic interaction between steady-state tipranavir/ritonavir and single-dose valacyclovir in healthy volunteers.
John P Sabo, Xiuyu Julie Cong, Michael-Friedrich Kraft, Lacey Wallace, Mark A Castles, Thomas R MacGregor

Eur J Clin Pharmacol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant administration of BILR 355/r with emtricitabine/tenofovir disoproxil fumarate increases exposure to emtricitabine and tenofovir: a randomized, open-label, prospective study.
Fenglei Huang, Paul Scholl, David B Huang, Thomas R MacGregor, Mitchell E Taub

Basic Clin Pharmacol Toxicol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic characterization of three doses of tipranavir boosted with ritonavir on highly active antiretroviral therapy in treatment-experienced HIV-1 patients.
Frank D Goebel, Thomas R MacGregor, John P Sabo, Mark Castles, Philip A Johnson

HIV Clin Trials· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of nevirapine bioavailability from targeted sites in the human gastrointestinal tract.
Sreeraj Macha, Chan-Loi Yong, Thomas R MacGregor, Mark Castles, Anne-Marie Quinson

J Clin Pharmacol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro-in vivo correlation for nevirapine extended release tablets.
Sreeraj Macha, Chan-Loi Yong, Todd Darrington, Mark S Davis, Thomas R MacGregor

Biopharm Drug Dispos· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic assessment of nevirapine and metabolites in human immunodeficiency virus type 1-infected patients with hepatic fibrosis.
Anna Maria Cammett, Thomas R MacGregor, Jan M Wruck, Franco Felizarta, Patrick Miailhes

Antimicrob Agents Chemother· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a role for cardiopulmonary exercise testing before major urological surgery.
Thomas MacGregor, Nilay Patel, Christopher Blick, Manit Arya, Asif Muneer

BJU Int· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of BILR 355 after multiple oral doses coadministered with a low dose of ritonavir.
Fenglei Huang, Kristin Drda, Thomas R MacGregor, Joseph Scherer, Lois Rowland

Antimicrob Agents Chemother· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and safety evaluation of BILR 355, a second-generation nonnucleoside reverse transcriptase inhibitor, in healthy volunteers.
Fenglei Huang, Michael Koenen-Bergmann, Thomas R Macgregor, Arne Ring, Susan Hattox

Antimicrob Agents Chemother· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis